Krystal Biotech (KRYS) Change in Inventory (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Change in Inventory of $958000.0 for Q2 2026, up 208.86% year-over-year from $310169.2 in Q2 2025, and up 294.24% on a QoQ basis from $243000.0 in Q1 2026.
Krystal Biotech (KRYS) Change in Inventory (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Change in Inventory for 4 years, with the latest figure at $958000.0 in Q2 2026.
- Change in Inventory for Q2 2026 came in at $958000.0, up 208.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.0 million (down 34.93% YoY), and the FY2025 annual result was $6.3 million, down 47.21% from the prior year.
- Change in Inventory climbed to $958000.0 in Q2 2026, from $243000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $6.5 million in Q4 2024 and troughed at -$880000.0 in Q2 2025.
- A 4-year average of $1.8 million and a median of $1.1 million in 2025 frame the typical range for Change in Inventory.
- The largest YoY upside for Change in Inventory was 1225.41% in 2024 against a maximum downside of 158.5% in 2024.
- A 4-year view of Change in Inventory shows it stood at $492000.0 in 2023, then jumped by 1225.41% to $6.5 million in 2024, then slumped by 83.78% to $1.1 million in 2025, then retreated by 9.45% to $958000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $958000.0 in Q2 2026, $243000.0 in Q1 2026, and $1.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 958,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 958,000.00 |
| Jun 30, 2026 | 958,000.00 |
| Mar 31, 2026 | 243,000.00 |
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | -880,000.00 |
| Jun 30, 2025 | -880,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | -530,000.00 |
| Jun 30, 2024 | -530,000.00 |
| Mar 31, 2024 | 2.24 Mn |
| Mar 31, 2024 | 2.24 Mn |